(Total Views: 394)
Posted On: 12/07/2019 7:12:58 AM
Post# of 154912
To make a long story short, blocking CCR5 interferes with a wide variety of immune processes that cancer hijacks to cause tumor growth and proliferation.
Which is why in an earlier post responding to our use with Keytruda I thought it unnecessary.
Quote:
For example, EMT has been associated with PD-L1 expression, particularly in lung cancer. Increased levels of PD-L1 suppresses the immune system which allows the cancer to spread more easily.
Which is why in an earlier post responding to our use with Keytruda I thought it unnecessary.
(2)
(0)
